There is a newer version
of
this Subtitle
2019 Maryland Code
Health - General
Title 21 - Food, Drugs, and Cosmetics
Subtitle 2C - Prescription Drug Affordability Board
- § 21-2C-01. Definitions.
- § 21-2C-02. Prescription Drug Affordability Board.
- § 21-2C-03. Membership.
- § 21-2C-04. Prescription Drug Affordability Stakeholder Council.
- § 21-2C-05. Disclosure of conflicts of interest.
- § 21-2C-06. Acceptance of gratuities prohibited.
- § 21-2C-07. Study and report -- Pharmaceutical distribution and payment system in State; policy options used in other states and countries.
- § 21-2C-08. Collection, review, and use of transparency data for prescription drug products.
- § 21-2C-09. Cost review of prescription drug products with affordability challenges.
- § 21-2C-10. Confidentiality.
- § 21-2C-11. Funding source.
- § 21-2C-12. Enforcement.
- § 21-2C-13. Drafting action plan for implementing process to set upper payment limits for prescription drug products [Section subject to abrogation]
- § 21-2C-13. Drafting action plan for implementing process to set upper payment limits for prescription drug products. (Abrogation of section effective January 1, 2023.)
- § 21-2C-14. Appeals of Board decisions [Section enacted subject to contingency]
- § 21-2C-15. Board and Stakeholder Council report and recommendation concerning upper payment limits [Section enacted subject to contingency]
Disclaimer: These codes may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.